Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml
Synfacts 2010(3): 0253-0253
DOI: 10.1055/s-0029-1219297
DOI: 10.1055/s-0029-1219297
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag
Stuttgart ˙ New York
Synthesis of the NK1 Receptor Antagonist GW597599
G. Guercio*, S. Bacchi et al.*
GlaxoSmithKline Medicines Research Center, Verona, Italy; Sanofi-Aventis R&D Centre, Toulouse and Pharmasynthese, Saint Pierre lès Elbeuf, France
Further Information
Publication History
Publication Date:
18 February 2010 (online)
![](https://www.thieme-connect.de/media/synfacts/201003/lookinside/thumbnails/10.1055-s-0029-1219297-1.jpg)
Significance
GW597599 is an NK1 receptor antagonist being developed for the treatment of chemotherapy-induced emesis. Noteworthy features are (a) the easy epimerization of the Schiff base derived from E thereby enabling a crystallization-induced diastereoselection and (b) a synthesis of the carbamoyl chloride J that avoids the use of triphosgene.